LumiraDx (LumiraDx) Days Payable : 134.79 (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is LumiraDx Days Payable?

LumiraDx's average Accounts Payable for the three months ended in Jun. 2023 was $45.7 Mil. LumiraDx's Cost of Goods Sold for the three months ended in Jun. 2023 was $30.9 Mil. Hence, LumiraDx's Days Payable for the three months ended in Jun. 2023 was 134.79.

The historical rank and industry rank for LumiraDx's Days Payable or its related term are showing as below:

LMDXF' s Days Payable Range Over the Past 10 Years
Min: 55.81 Med: 79.53 Max: 245.14
Current: 80.99

During the past 4 years, LumiraDx's highest Days Payable was 245.14. The lowest was 55.81. And the median was 79.53.

LMDXF's Days Payable is ranked better than
57.62% of 210 companies
in the Medical Diagnostics & Research industry
Industry Median: 68.79 vs LMDXF: 80.99

LumiraDx's Days Payable declined from Jun. 2022 (173.92) to Jun. 2023 (134.79). It may suggest that LumiraDx accelerated paying its suppliers.

LumiraDx Days Payable Historical Data

The historical data trend for LumiraDx's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LumiraDx Days Payable Chart

LumiraDx Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Days Payable

245.14

79.53

55.81

LumiraDx Quarterly Data
	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Days Payable	Get a 7-Day Free Trial								173.92	180.85	37.86	176.31	134.79

Competitive Comparison of LumiraDx's Days Payable

For the Diagnostics & Research subindustry, LumiraDx's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LumiraDx's Days Payable Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, LumiraDx's Days Payable distribution charts can be found below:

* The bar in red indicates where LumiraDx's Days Payable falls into.

LumiraDx Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

LumiraDx's Days Payable for the fiscal year that ended in Dec. 2022 is calculated as

	Days Payable (A: Dec. 2022 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2021 )	+	Accounts Payable (A: Dec. 2022 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2022 )	*	Days in Period
=	( (59.718	+	28.897)	/	2 )	/	289.778	*	365
=	44.3075					/	289.778	*	365
=	55.81

LumiraDx's Days Payable for the quarter that ended in Jun. 2023 is calculated as:

	Days Payable (Q: Jun. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Mar. 2023 )	+	Accounts Payable (Q: Jun. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2023 )	*	Days in Period
=	( (63.58	+	27.725)	/	2 )	/	30.905	*	365 / 4
=	45.6525					/	30.905	*	365 / 4
=	134.79

LumiraDx Days Payable Related Terms

Thank you for viewing the detailed overview of LumiraDx's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

LumiraDx (LumiraDx) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LumiraDx Ltd (OTCPK:LMDXF) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

C/o Ocorian Trust (Cayman) Ltd, Windward 3, P.O. Box 1350, Regatta Office Park, Grand Cayman, CYM, KY1-1108

Website

https://www.lumiradx.com

LumiraDx Ltd is a next-generation point of care diagnostics company. It manufactures and commercializes an innovative diagnostic Platform that supports a broad menu of tests with lab comparable performance at the point of care. Geographical presence in United States, Italy, UK, Germany, Colombia, Sweden and Other countries. Majority revenue derives from U.S.